Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Wockhardt
Wockhardt
BSE: 532300|NSE: WOCKPHARMA|ISIN: INE049B01025|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 13:30
629.55
11.95 (1.93%)
VOLUME 129,579
LIVE
NSE
Apr 23, 17:00
659.00
3.8 (0.58%)
VOLUME 953,309
News on Wockhardt
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
The State Drug Controller, Himachal Pradesh suspends Wockhardt's drug manufacture, sale, distribution

10.30 am | 24 Apr 2014 |  Source: Moneycontrol.com

Wockhardt has informed that The State Drug Controller, Himachal Pradesh, has suspended the manufacture, sale or distribution of Fixed Dose Combination...

Exit Wockhardt, says Sharmila Joshi 

3.36 pm | 10 Apr 2014 |  Source: CNBC-TV18

Sharmila Joshi of sharmilajoshi.com is of the view that one may exit Wockhardt....

Keep Cipla in portfolio, avoid Wockhardt: Gopi Suvanam 

5.10 pm | 03 Apr 2014 |  Source: CNBC-TV18

Gopi Suvanam, founder at InvestWorks prefers Ranbaxy Laboratories, Sun Pharmaceutical Industries, Lupin and Cipla. He feels that one should avoid Wock...

Wockhardt clarifies on increase in volume

12.36 pm | 03 Apr 2014 |  Source: Moneycontrol.com

With reference to increase in volume, Wockhardt has clarified that the Company has been informing the exchange about events, information etc. includin...

Buy Wockhardt, advises Sudarhan Sukhani 

10.47 am | 03 Apr 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may buy Wockhardt....

Pharma cos up on hopes of abating quality issues: JM Fin 

10.29 am | 03 Apr 2014 |  Source: CNBC-TV18

Anmol Ganjoo, VP-institutional equities, JM Financial says the recent spate of good news has led the market to believe that the issues face by the pha...

Novartis sues Biocon for patent infringement on Galvus 

11.14 pm | 02 Apr 2014 |  Source: CNBC-TV18

In yet another patent infringement battles in India, Swiss drug maker Novartis has taken Indian biotech firm Biocon to court on anti-diabetes drug. No...

India generic drugmakers' woes put new focus on quality

8.42 am | 26 Mar 2014 |  Source: Reuters

In the short term, that is expected to benefit larger global competitors, such as Teva Pharmaceutical Industries Ltd, Actavis Plc and Mylan Inc, which...

India ready to discuss IPR norms at WTO if US wants: Sharma

3.39 pm | 23 Mar 2014 |  Source: PTI

"If they (the US) want a discussion in WTO (World Trade Organization), we are more than ready because we are not in any breach. We are very clear," Co...

Sell Wockhardt; target of Rs 398: AnandRathi

5.46 pm | 24 Feb 2014 |  Source: Moneycontrol.com

AnandRathi Securities is bearish on Wockhardt and has recommended sell rating on the stock with a target price of Rs 398 in its February 12, 2014 rese...

Wockhardt reports disappointing Q3 earnings 

8.05 pm | 10 Feb 2014 |  Source: Moneycontrol.com

Wockhardt reports disappointing Q3 earnings...

Wockhardt Q3 net profit falls 29% post US FDA alert

11.28 am | 10 Feb 2014 |  Source: Reuters

In November, the US Food and Drug Administration issued an import alert, effectively a ban, against Wockhardt's Chikalthana plant in western India. Th...

Pharma companies revenues to rise 12% in Q3: Anand Rathi

5.34 pm | 03 Jan 2014 |  Source: Moneycontrol.com

Pharma companies are likely to post 12 percent Y-o-Y revenue growth. However, excluding Wockhardt (FDA issues) and Fortis Healthcare (divestments), re...

Wockhardt Q2 net dips 69% to Rs 138cr

2.27 pm | 25 Oct 2013 |  Source: PTI

The company had posted a consolidated net profit of Rs 453.55 crore in the same quarter last fiscal, Wockhardt Ltd said in a filing to the BSE. ...

1 2 3
Quick Links for Wockhardt
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.